POU2AF1 anticorps (AA 148-255)

N° du produit ABIN7870754

Cet anticorps Souris Monoclonal détecte spécifiquement POU2AF1 dans WB et IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour POU2AF1 anticorps (AA 148-255) (ABIN7870754)

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp POU2AF1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: BOB1-2422

Détail du produit anti-POU2AF1 anticorps

Épitope: AA 148-255

Fonction: BOB.1 Antibody

Purification: Protein G affinity chromatography

Immunogène: A portion of amino acids 148-255 from the human protein was used as the immunogen for the BOB.1 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the BOB.1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store the BOB.1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur POU2AF1

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Autre désignation: BOB.1

Sujet: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.

UniProt: Q16633